1. Academic Validation
  2. Cancer preventive agents 9. Betulinic acid derivatives as potent cancer chemopreventive agents

Cancer preventive agents 9. Betulinic acid derivatives as potent cancer chemopreventive agents

  • Bioorg Med Chem Lett. 2009 Jul 1;19(13):3378-81. doi: 10.1016/j.bmcl.2009.05.050.
Kyoko Nakagawa-Goto 1 Koji Yamada Masahiko Taniguchi Harukuni Tokuda Kuo-Hsiung Lee
Affiliations

Affiliation

  • 1 Natural Products Research Laboratories, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC 27599, USA.
Abstract

C-3 esterifications of betulinic acid (BA, 1) and its A-ring homolog, ceanothic acid (CA, 2), were carried out to provide sixteen Terpenoids, 4-19, including nine new compounds (4-12). All synthesized compounds were evaluated in an in vitro antitumor-promoting assay using the Epstein-Barr virus early antigen (EBV-EA) activation induced by 12-O-tetradecanoylphorbol-13-acetate (TPA) in Raji cells. Among them, compounds 4-6, 11-14, 16, and 17 displayed remarkable inhibitory effects of EBV-EA activation. BA analog 6, which contains a prenyl-like group, showed the most potent inhibitory effect (100%, 76%, 37%, and 11% inhibition of EBA activation at 1000, 500, 100, and 10mol ratio/TPA, respectively, with IC(50) value of 285mol ratio/32pmol TPA). Compound 6 merits further development as a Cancer preventive agent.

Figures